QuickView for mRNA splicing, via spliceosome (biogroup)

1. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
2. Neural development of iPSCs derived from Autistic patients with BCKD-kinase mutations
3. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
4. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
5. Induced pluripotent stem cells derived from fibroblasts of Down's syndrome patients

There were no matches for mRNA splicing, via spliceosome

There were no clinical trials for mRNA splicing, via spliceosome